Northland Capital Markets Maintains Outperform on BrainsWay, Raises Price Target to $12.5
Portfolio Pulse from Benzinga Newsdesk
Northland Capital Markets has maintained an 'Outperform' rating on BrainsWay and raised its price target from $11 to $12.5, indicating a positive outlook for the company's stock.
October 03, 2024 | 12:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Northland Capital Markets has maintained an 'Outperform' rating on BrainsWay and increased the price target from $11 to $12.5, suggesting a positive short-term outlook for the stock.
The analyst's decision to maintain an 'Outperform' rating and raise the price target indicates confidence in BrainsWay's future performance. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100